AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2008
May 14, 2008
31801_dirs_2008-05-14_dff58462-2a95-463c-bd39-30fed1b1a90a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVANT IMMUNOTHERAPEUTICS INC (AVAN)
CIK: 0000744218
Period of Report: 2007-04-07
Reporting Person: Lorantis Holdings LTD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-04-07 | Cmmon Stock | J | 2811147 | — | Disposed | 0 | Direct |
Footnotes
F1: Securities distributed to shareholders of the Reporting Person in a voluntary liquidation proceeding except that 2% of such securities distributed to Parekh Enterprises Limited for services rendered.
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Capital/Financing Update
2026
Apr 2
Capital/Financing Update
2026
Apr 1
Major Shareholding Notification
2026
Mar 26